{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:19:44Z","timestamp":1761844784907},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0592","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T22:09:51Z","timestamp":1504303791000},"page":"457-463","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Calcium-Channel Blocker Benidipine-Based Combination Therapy on Cardiac Events\u3000\u2015 Subanalysis of the COPE Trial \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Seiji","family":"Umemoto","sequence":"first","affiliation":[{"name":"Center for Integrated Medical Research, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Morinomiya University of Medical Sciences"},{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Yamaguchi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Shin-oyama City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Kawana","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Tokyo Women\u2019s Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Science and Engineering for Sustainable Society, Faculty of Science and Engineering, Chuo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Saruta","sequence":"additional","affiliation":[{"name":"Keio University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. <i>Circ J<\/i> 2013; 77: 1923\u20131932.","DOI":"10.1253\/circj.CJ-13-0786"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Turin TC, Kita Y, Rumana N, Nakamura Y, Takashima N, Ichikawa M, et al. Ischemic stroke subtypes in a Japanese population: Takashima Stroke Registry, 1988\u20132004. <i>Stroke<\/i> 2010; 41: 1871\u20131876.","DOI":"10.1161\/STROKEAHA.110.581033"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. <i>Circulation<\/i> 2000; 101: 1102\u20131108.","DOI":"10.1161\/01.CIR.101.10.1102"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, et al. The who, what, why, when, how and where of vasospastic angina. <i>Circ J<\/i> 2016; 80: 289\u2013298.","DOI":"10.1253\/circj.CJ-15-1202"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). <i>Hypertens Res<\/i> 2014; 37: 253\u2013387.","DOI":"10.1038\/hr.2014.20"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). <i>Hypertens Res<\/i> 2009; 32: 3\u2013107.","DOI":"10.1038\/hr.2009.34"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yao K, Nagashima K, Miki H. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. <i>J Pharmacol Sci<\/i> 2006; 100: 243\u2013261.","DOI":"10.1254\/jphs.DTJ05001X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, et al. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. <i>Hypertens Res<\/i> 2011; 34: 268\u2013273.","DOI":"10.1038\/hr.2010.221"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tani S, Takahashi A, Nagao K, Hirayama A. Effects of the T\/L-type calcium channel blocker benidipine on albuminuria and plasma aldosterone concentration: A pilot study involving switching from L-type calcium channel blockers to benidipine. <i>Int Heart J<\/i> 2014; 55: 519\u2013525.","DOI":"10.1536\/ihj.14-034"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Unger T, Paulis L, Sica DA. Therapeutic perspectives in hypertension: Novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches. <i>Eur Heart J<\/i> 2011; 32: 2739\u20132747.","DOI":"10.1093\/eurheartj\/ehr253"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kosaka H, Hirayama K, Yoda N, Sasaki K, Kitayama T, Kusaka H, et al. The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family. <i>Eur J Pharmacol<\/i> 2010; 635: 49\u201355.","DOI":"10.1016\/j.ejphar.2010.03.018"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fuji Y, Suzuki H, Katsumata H, Nakajima S, Saruta T. Hormonal and renal responses to oral once-daily calcium entry blocker in normotensive and hypertensive persons. <i>J Cardiovasc Pharmacol<\/i> 1988; 11: 438\u2013443.","DOI":"10.1097\/00005344-198804000-00009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nishigaki K, Inoue Y, Yamanouchi Y, Fukumoto Y, Yasuda S, Sueda S, et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina. <i>Circ J<\/i> 2010; 74: 1943\u20131950.","DOI":"10.1253\/circj.CJ-10-0292"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ogihara T, Matsuzaki M, Matsuoka H, Shimamoto K, Shimada K, Rakugi H, et al. The Combination Therapy of hypertension to Prevent Cardiovascular Events (COPE) trial: Rationale and design. <i>Hypertens Res<\/i> 2005; 28: 331\u2013338.","DOI":"10.1291\/hypres.28.331"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, et al. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: A randomized controlled trial. <i>J Hypertens<\/i> 2011; 29: 1649\u20131659.","DOI":"10.1097\/HJH.0b013e328348345d"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ogihara T, Matsuzaki M, Umemoto S, Rakugi H, Matsuoka H, Shimada K, et al. Combination therapy for hypertension in the elderly: A sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial. <i>Hypertens Res<\/i> 2012; 35: 441\u2013448.","DOI":"10.1038\/hr.2011.216"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Umemoto S, Ogihara T, Rakugi H, Matsumoto M, Kitagawa K, Shimada K, et al. Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: The COPE trial. <i>Hypertens Res<\/i> 2013; 36: 1088\u20131095.","DOI":"10.1038\/hr.2013.100"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC\/AHA\/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). <i>J Am Coll Cardiol<\/i> 2003; 42: 1318\u20131333.","DOI":"10.1016\/j.jacc.2003.08.011"},{"key":"19","unstructured":"19. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC\/AHA\/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). <i>J Am Soc Echocardiogr<\/i> 2003; 16: 1091\u20131110."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. French JK, White HD. Clinical implications of the new definition of myocardial infarction. <i>Heart<\/i> 2004; 90: 99\u2013106.","DOI":"10.1136\/heart.90.1.99"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. <i>Circulation<\/i> 2003; 108: 2543\u20132549.","DOI":"10.1161\/01.CIR.0000100560.46946.EA"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. <i>Eur Heart J<\/i> 2003; 24: 13\u201315.","DOI":"10.1016\/S0195-0668X(02)00809-6"},{"key":"23","unstructured":"23. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? <i>Lancet<\/i> 2005; 366: 1545\u20131553."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. <i>Lancet<\/i> 2016; 387: 957\u2013967.","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. JCS Joint Working Group. Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011): Digest version. <i>Circ J<\/i> 2013; 77: 231\u2013248.","DOI":"10.1253\/circj.CJ-66-0053"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Taverny G, Mimouni Y, LeDigarcher A, Chevalier P, Thijs L, Wright JM, et al. Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals. <i>Cochrane Database Syst Rev<\/i> 2016; 3: CD011745.","DOI":"10.1002\/14651858.CD011745.pub2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Makani H, Bangalore S, Romero J, Htyte N, Berrios RS, Makwana H, et al. Peripheral edema associated with calcium channel blockers: Incidence and withdrawal rate--a meta-analysis of randomized trials. <i>J Hypertens<\/i> 2011; 29: 1270\u20131280.","DOI":"10.1097\/HJH.0b013e3283472643"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: Epidemiology, mechanisms and management. <i>Nat Rev Nephrol<\/i> 2016; 12: 610\u2013623.","DOI":"10.1038\/nrneph.2016.113"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, et al. Combination therapy for hypertension in patients with CKD: A subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial. <i>Hypertens Res<\/i> 2013; 36: 947\u2013958.","DOI":"10.1038\/hr.2013.63"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hayashi K. L-\/T-type Ca channel blockers for kidney protection: Ready for sophisticated use of Ca channel blockers. <i>Hypertens Res<\/i> 2011; 34: 910\u2013912.","DOI":"10.1038\/hr.2011.74"},{"key":"31","unstructured":"31. Bakris GL. Maximizing cardiorenal benefit in the management of hypertension: Achieve blood pressure goals. <i>J Clin Hypertens<\/i> 1999; 1: 141\u2013147."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of Hypertension Writing Group. Combination therapy in hypertension. <i>J Clin Hypertens (Greenwich)<\/i> 2011; 13: 146\u2013154.","DOI":"10.1111\/j.1751-7176.2010.00397.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sever PS, Messerli FH. Hypertension management 2011: Optimal combination therapy. <i>Eur Heart J<\/i> 2011; 32: 2499\u20132506.","DOI":"10.1093\/eurheartj\/ehr177"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-0592\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T02:07:43Z","timestamp":1570068463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-0592\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0592","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2018]]}}}